SIEMENS HEALTHINEERS AG (SHL.DE) Stock Fundamental Analysis
Europe - FRA:SHL - DE000SHL1006 - Common Stock
49.34 EUR
+0.74 (+1.52%)
We assign a fundamental rating of 5 out of 10 to SHL. SHL was compared to 59 industry peers in the Health Care Equipment & Supplies industry. While SHL is still in line with the averages on profitability rating, there are concerns on its financial health. SHL is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year SHL was profitable.
In the past year SHL had a positive cash flow from operations.
In the past 5 years SHL has always been profitable.
Each year in the past 5 years SHL had a positive operating cash flow.
1.2 Ratios
SHL's Return On Assets of 4.87% is fine compared to the rest of the industry. SHL outperforms 62.71% of its industry peers.
The Return On Equity of SHL (12.29%) is better than 74.58% of its industry peers.
The Return On Invested Capital of SHL (7.89%) is better than 69.49% of its industry peers.
SHL had an Average Return On Invested Capital over the past 3 years of 5.87%. This is below the industry average of 9.04%.
The 3 year average ROIC (5.87%) for SHL is below the current ROIC(7.89%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.87% | ||
| ROE | 12.29% | ||
| ROIC | 7.89% |
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
1.3 Margins
With a decent Profit Margin value of 9.29%, SHL is doing good in the industry, outperforming 66.10% of the companies in the same industry.
SHL's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 13.76%, SHL is in the better half of the industry, outperforming 62.71% of the companies in the same industry.
In the last couple of years the Operating Margin of SHL has declined.
With a Gross Margin value of 38.76%, SHL is not doing good in the industry: 76.27% of the companies in the same industry are doing better.
SHL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.76% | ||
| PM (TTM) | 9.29% | ||
| GM | 38.76% |
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SHL is still creating some value.
Compared to 1 year ago, SHL has more shares outstanding
Compared to 5 years ago, SHL has more shares outstanding
The debt/assets ratio for SHL has been reduced compared to a year ago.
2.2 Solvency
SHL has an Altman-Z score of 2.11. This is not the best score and indicates that SHL is in the grey zone with still only limited risk for bankruptcy at the moment.
SHL's Altman-Z score of 2.11 is in line compared to the rest of the industry. SHL outperforms 44.07% of its industry peers.
SHL has a debt to FCF ratio of 5.10. This is a neutral value as SHL would need 5.10 years to pay back of all of its debts.
SHL has a Debt to FCF ratio (5.10) which is in line with its industry peers.
SHL has a Debt/Equity ratio of 0.66. This is a neutral value indicating SHL is somewhat dependend on debt financing.
The Debt to Equity ratio of SHL (0.66) is worse than 71.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 5.1 | ||
| Altman-Z | 2.11 |
ROIC/WACC1.27
WACC6.22%
2.3 Liquidity
A Current Ratio of 1.12 indicates that SHL should not have too much problems paying its short term obligations.
The Current ratio of SHL (1.12) is worse than 69.49% of its industry peers.
A Quick Ratio of 0.77 indicates that SHL may have some problems paying its short term obligations.
With a Quick ratio value of 0.77, SHL is not doing good in the industry: 71.19% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.12 | ||
| Quick Ratio | 0.77 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 11.21% over the past year.
SHL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.27% yearly.
Looking at the last year, SHL shows a small growth in Revenue. The Revenue has grown by 5.85% in the last year.
SHL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.02% yearly.
EPS 1Y (TTM)11.21%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%23.08%
Revenue 1Y (TTM)5.85%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%4.41%
3.2 Future
The Earnings Per Share is expected to grow by 9.71% on average over the next years. This is quite good.
Based on estimates for the next years, SHL will show a small growth in Revenue. The Revenue will grow by 5.62% on average per year.
EPS Next Y9.68%
EPS Next 2Y8.26%
EPS Next 3Y9.53%
EPS Next 5Y9.71%
Revenue Next Year4.89%
Revenue Next 2Y4.63%
Revenue Next 3Y5.08%
Revenue Next 5Y5.62%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
SHL is valuated rather expensively with a Price/Earnings ratio of 20.73.
SHL's Price/Earnings ratio is a bit cheaper when compared to the industry. SHL is cheaper than 79.66% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.57, SHL is valued a bit cheaper.
A Price/Forward Earnings ratio of 18.88 indicates a rather expensive valuation of SHL.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SHL indicates a somewhat cheap valuation: SHL is cheaper than 66.10% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.09. SHL is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.73 | ||
| Fwd PE | 18.88 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as SHL.
84.75% of the companies in the same industry are more expensive than SHL, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.09 | ||
| EV/EBITDA | 14.92 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
SHL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.14
PEG (5Y)2.85
EPS Next 2Y8.26%
EPS Next 3Y9.53%
5. Dividend
5.1 Amount
SHL has a Yearly Dividend Yield of 2.00%.
Compared to an average industry Dividend Yield of 2.36, SHL pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.32, SHL has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2% |
5.2 History
On average, the dividend of SHL grows each year by 6.35%, which is quite nice.
Dividend Growth(5Y)6.35%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
SHL pays out 49.08% of its income as dividend. This is a bit on the high side, but may be sustainable.
SHL's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP49.08%
EPS Next 2Y8.26%
EPS Next 3Y9.53%
FRA:SHL (10/22/2025, 7:00:00 PM)
49.34
+0.74 (+1.52%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners12.27%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap55.66B
Revenue(TTM)23.38B
Net Income(TTM)2.17B
Analysts83.7
Price Target61.88 (25.42%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2% |
Yearly Dividend0.95
Dividend Growth(5Y)6.35%
DP49.08%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.66%
Min EPS beat(2)-2.04%
Max EPS beat(2)13.36%
EPS beat(4)3
Avg EPS beat(4)5.82%
Min EPS beat(4)-2.04%
Max EPS beat(4)13.36%
EPS beat(8)5
Avg EPS beat(8)3.25%
EPS beat(12)8
Avg EPS beat(12)3.67%
EPS beat(16)10
Avg EPS beat(16)2.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.25%
Min Revenue beat(2)-0.77%
Max Revenue beat(2)0.27%
Revenue beat(4)2
Avg Revenue beat(4)-0.01%
Min Revenue beat(4)-0.81%
Max Revenue beat(4)1.29%
Revenue beat(8)3
Avg Revenue beat(8)-0.4%
Revenue beat(12)4
Avg Revenue beat(12)-0.45%
Revenue beat(16)8
Avg Revenue beat(16)0.12%
PT rev (1m)0%
PT rev (3m)-0.53%
EPS NQ rev (1m)-0.24%
EPS NQ rev (3m)-8.5%
EPS NY rev (1m)0.1%
EPS NY rev (3m)-2.25%
Revenue NQ rev (1m)-0.11%
Revenue NQ rev (3m)-1.03%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)-0.76%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.73 | ||
| Fwd PE | 18.88 | ||
| P/S | 2.38 | ||
| P/FCF | 18.09 | ||
| P/OCF | 14.47 | ||
| P/B | 3.15 | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.92 |
EPS(TTM)2.38
EY4.82%
EPS(NY)2.61
Fwd EY5.3%
FCF(TTM)2.73
FCFY5.53%
OCF(TTM)3.41
OCFY6.91%
SpS20.73
BVpS15.67
TBVpS-5.42
PEG (NY)2.14
PEG (5Y)2.85
Graham Number28.97
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.87% | ||
| ROE | 12.29% | ||
| ROCE | 10.07% | ||
| ROIC | 7.89% | ||
| ROICexc | 8.64% | ||
| ROICexgc | 46.76% | ||
| OM | 13.76% | ||
| PM (TTM) | 9.29% | ||
| GM | 38.76% | ||
| FCFM | 13.16% |
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
ROICexc(3y)6.25%
ROICexc(5y)6.86%
ROICexgc(3y)30.57%
ROICexgc(5y)31.67%
ROCE(3y)7.49%
ROCE(5y)8.29%
ROICexgc growth 3Y-8.79%
ROICexgc growth 5Y-3.88%
ROICexc growth 3Y1.69%
ROICexc growth 5Y-10.54%
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
F-Score8
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 5.1 | ||
| Debt/EBITDA | 2.58 | ||
| Cap/Depr | 59.37% | ||
| Cap/Sales | 3.29% | ||
| Interest Coverage | 7.09 | ||
| Cash Conversion | 85.2% | ||
| Profit Quality | 141.62% | ||
| Current Ratio | 1.12 | ||
| Quick Ratio | 0.77 | ||
| Altman-Z | 2.11 |
F-Score8
WACC6.22%
ROIC/WACC1.27
Cap/Depr(3y)58.06%
Cap/Depr(5y)61.48%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3.7%
Profit Quality(3y)91.88%
Profit Quality(5y)100.74%
High Growth Momentum
Growth
EPS 1Y (TTM)11.21%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%23.08%
EPS Next Y9.68%
EPS Next 2Y8.26%
EPS Next 3Y9.53%
EPS Next 5Y9.71%
Revenue 1Y (TTM)5.85%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%4.41%
Revenue Next Year4.89%
Revenue Next 2Y4.63%
Revenue Next 3Y5.08%
Revenue Next 5Y5.62%
EBIT growth 1Y18.19%
EBIT growth 3Y3.18%
EBIT growth 5Y4.12%
EBIT Next Year49.21%
EBIT Next 3Y20.47%
EBIT Next 5Y15.42%
FCF growth 1Y161.12%
FCF growth 3Y-1.94%
FCF growth 5Y15.48%
OCF growth 1Y86.79%
OCF growth 3Y-1.23%
OCF growth 5Y11.83%